These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
671 related items for PubMed ID: 16230673
1. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. Alberts SR, Horvath WL, Sternfeld WC, Goldberg RM, Mahoney MR, Dakhil SR, Levitt R, Rowland K, Nair S, Sargent DJ, Donohue JH. J Clin Oncol; 2005 Dec 20; 23(36):9243-9. PubMed ID: 16230673 [Abstract] [Full Text] [Related]
3. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure. Boige V, Malka D, Elias D, Castaing M, De Baere T, Goere D, Dromain C, Pocard M, Ducreux M. Ann Surg Oncol; 2008 Jan 20; 15(1):219-26. PubMed ID: 17896145 [Abstract] [Full Text] [Related]
7. Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases. Goéré D, Deshaies I, de Baere T, Boige V, Malka D, Dumont F, Dromain C, Ducreux M, Elias D. Ann Surg; 2010 Apr 20; 251(4):686-91. PubMed ID: 20224373 [Abstract] [Full Text] [Related]
13. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases. Benoist S, Nordlinger B. Ann Surg Oncol; 2009 Sep 01; 16(9):2385-90. PubMed ID: 19554377 [Abstract] [Full Text] [Related]
15. Outcome of metastatic colorectal cancer: analysis of a consecutive series of 229 patients. The impact of a multidisciplinary approach. Sperti E, Faggiuolo R, Gerbino A, Magnino A, Muratore A, Ortega C, Ferraris R, Leone F, Capussotti L, Aglietta M. Dis Colon Rectum; 2006 Oct 01; 49(10):1596-601. PubMed ID: 16988853 [Abstract] [Full Text] [Related]
17. Response to chemotherapy predicts survival following resection of hepatic colo-rectal metastases in patients treated with neoadjuvant therapy. Small RM, Lubezky N, Shmueli E, Figer A, Aderka D, Nakache R, Klausner JM, Ben-Haim M. J Surg Oncol; 2009 Feb 01; 99(2):93-8. PubMed ID: 19065637 [Abstract] [Full Text] [Related]
19. OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study. Tournigand C, Cervantes A, Figer A, Lledo G, Flesch M, Buyse M, Mineur L, Carola E, Etienne PL, Rivera F, Chirivella I, Perez-Staub N, Louvet C, André T, Tabah-Fisch I, de Gramont A. J Clin Oncol; 2006 Jan 20; 24(3):394-400. PubMed ID: 16421419 [Abstract] [Full Text] [Related]
20. Nonresponse to pre-operative chemotherapy does not preclude long-term survival after liver resection in patients with colorectal liver metastases. Neumann UP, Thelen A, Röcken C, Seehofer D, Bahra M, Riess H, Jonas S, Schmeding M, Pratschke J, Bova R, Neuhaus P. Surgery; 2009 Jul 20; 146(1):52-9. PubMed ID: 19541010 [Abstract] [Full Text] [Related] Page: [Next] [New Search]